Natus Medical Continues Its Restructuring – Motley Fool

Natus Medical (NASDAQ:BABY) continued its restructuring, which resulted in an ugly first quarter. Fortunately, with expectations low, investors were able to shrug it off in hopes that the medical device maker will be able to come out the other side a better company.

Natus Medical results: The raw numbers

Read the full article at:

Related Posts


Q1 2019

Q1 2018

Year-Over-Year Change


$114.8 million

$128.6 million


Income from operations

($24.2 million)

($2.7 million)


Earnings per share (EPS)




Adjusted EPS